This morning before the start of trading on the New York Stock Exchange and Nasdaq Amgen (NASDAQ: AMGN) announced that it was purchasing biotech company Micromet Incorporated (NASDAQ: MITI) for a blockbuster $1.16 billion acquisition.

Micromet announced that it also agreed to the buyout and shareholders will receive $11 in cash per every share that they own.

read more

This post is syndicated, read original article.